Skip to main content

Day: March 2, 2021

Clearside Biomedical Announces Completion of Patient Dosing in First Cohort of Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) for the Treatment of Wet AMD

– Initial Safety Data from First Cohort Expected Mid-2021 –ALPHARETTA, Ga., March 02, 2021 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today completion of dosing in the first cohort of OASIS, its ongoing Phase 1/2a clinical trial of CLS-AX (axitinib injectable suspension) in patients with neovascular age-related macular degeneration (wet AMD).OASIS is a U.S.-based, multi-center, open-label, dose-escalation trial in wet AMD patients to assess the safety and tolerability of a single dose of CLS-AX administered by suprachoroidal injection. The first cohort of patients have received aflibercept at their first visit and a single dose of...

Continue reading

Orchard Therapeutics Reports 2020 Financial Results and Reviews Recent Accomplishments

$150M Strategic Financing Supports Execution into the First Half of 2023OTL-203 Achieves Proof of Concept (POC) in MPS-I Hurler Syndrome (MPS-IH); Registrational Trial Planned to Initiate by Year End 2021OTL-200 U.S. Filing Strategy for Metachromatic Leukodystrophy (MLD) Expected by Mid-2021R&D Organizational Leadership Changes AnnouncedBOSTON and LONDON, March 02, 2021 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today reported financial results for the year ended December 31, 2020, as well as recent accomplishments, 2021 strategic priorities and upcoming milestones, and related organizational leadership updates.Frank Thomas, president and chief operating officer said, “It is gratifying to witness the positive momentum Orchard has already established in early 2021 driven by solid execution....

Continue reading

TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2020 Financial Results

NEW YORK, March 02, 2021 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the fourth quarter and year ended December 31, 2020 and recent company developments, along with a business outlook for 2021.Michael S. Weiss, the Company’s Executive Chairman and Chief Executive Officer, stated, “2020 was a year of data and regulatory execution for us as we delivered results from our UNITY-NHL study that led to the approval of UKONIQ in relapsed/refractory MZL and FL and from UNITY-CLL that will be used to support the current rolling BLA submission for ublituximab in combination with umbralisib for patients with CLL.  We also announced the top line results from our ULTIMATE MS Phase 3 trials that will be used to support a BLA submission for ublituximab in MS.  These successful outcomes...

Continue reading

Antares Pharma Reports Fourth Quarter and Full-Year 2020 Financial and Operating Results

Full-Year 2020 Revenue Increases 21% Year-Over-Year to $149.6 MillionFull-Year 2020 Net Income Before Income Taxes of $9.9 Million, or $0.06 per ShareFull-Year 2020 Net Income of $56.2 Million, including a Net Tax Benefit of $46.3 millionEWING, N.J., March 02, 2021 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today reported financial and operating results for the fourth quarter ended December 31, 2020 with record revenue of $44.1 million and net income of $51.4 million, or basic and diluted earnings per share of $0.31 and $0.30, respectively, which included a net tax benefit of $46.3 million. The Company also reported record full-year 2020 revenue of $149.6 million and net income of $56.2 million, or basic and diluted earnings per share of $0.34 and $0.33, respectively....

Continue reading

GTreasury Acquires Coprocess, the Leader in Intercompany Netting Solutions

CHICAGO, March 02, 2021 (GLOBE NEWSWIRE) — GTreasury, a treasury and risk management platform provider, today announced the acquisition of Coprocess, the leading provider of intercompany netting solutions. Adding intercompany netting to the GTreasury platform and ecosystem gives corporate treasurers the ability to significantly streamline their settlement processes, cut costs by reducing payments and FX volumes, and add new automated efficiencies into their treasury workflows.“GTreasury continues to look for ways to empower corporate treasurers to do their jobs more effectively, more efficiently, and with less cost to their organizations,” said Renaat Ver Eecke, CEO, GTreasury. “The complexities of doing business across countries and across banks continues to grow, and the technologies that treasurers rely on must keep up with that...

Continue reading

PLBY Group Closes Previously Announced Acquisition of Lovers

LOS ANGELES, March 02, 2021 (GLOBE NEWSWIRE) — PLBY Group, Inc. (Nasdaq: PLBY) (the “Company”), a leading pleasure and leisure lifestyle company and owner of Playboy, one of the most recognizable and iconic brands in the world, today announced the completion of its previously announced deal to acquire TLA Acquisition Corp., the parent company of the Lovers family of stores (“Lovers”), a leading omni-channel online and brick-and-mortar sexual wellness chain, with 41 stores in five states.The acquisition of 100% of the equity of Lovers was completed for a purchase price of $25M of cash. Lovers is expected to generate $45M in revenue over the next twelve months, and approximately $5M of Adjusted EBITDA. The deal is immediately accretive to shareholders on a per share basis. Barbara Cook, CEO of Lovers, will join PLBY Group as Executive...

Continue reading

REPEAT – EarthRenew Signs Letter of Intent for New Facility on 50,000 Head Feedlot in Colorado

Highlights:EarthRenew advances its growth strategy into the United States through the signing of a non-binding letter of intent with Diamond Feeders, the owner of a 50,000 head feedlot in Colorado.The new site is projected to provide EarthRenew with strategic access to the southwestern United States, one of the largest organic markets in the world.The new site is being designed to produce over 40,000 tonnes of finished product per year and can serve as a blending and granulation facility to meet United States demand.Once binding agreements are signed, we anticipate it will take approximately 12 months to permit, design and construct the blending and granulation facility, and a further 12 months to permit, design and construct the EarthRenew production facility.We continue to scout additional United States sites to support a broader growth...

Continue reading

COMPASS Pathways plc to announce fourth quarter and full year 2020 financial results on 9 March 2021

New York, March 02, 2021 (GLOBE NEWSWIRE) — London, UK – 2 March 2021 COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the fourth quarter and year ended 31 December 2020, and provide an update on recent business developments, on 9 March 2021.The management team will host a conference call at 1:00pm GMT (8.00am ET) on 9 March. The call can be accessed by dialling (833) 665-0659 from the United States, +1 (914) 987-7313 internationally, and 0800 028 8438 from the UK, followed by the conference ID: 5558345.The call will also be webcast on the Investors section of the COMPASS Pathways website. The webcast will be archived for 30 days.-Ends-About COMPASS PathwaysCOMPASS Pathways...

Continue reading

Talenom has a new office in Ivalo

Talenom Plc, Press release, 2 March 2021 at 14:00 EETTalenom has a new office in IvaloTalenom Plc has acquired Tilipalvelu Pirkko Kemppainen Oy’s accounting business in Ivalo on 1 March 2021. Tilipalvelu Pirkko Kemppainen Oy is an Ivalo-based full-service accounting company established in 1987. The company has a branch office in Rovaniemi. The company is the northernmost authorised accounting company in Finland. The total sales of the acquired business transferred to Talenom amount to around 0.4 million euros. In addition to the entrepreneur family, the company has two employees. The company’s entire personnel will be transferred to Talenom in connection with the acquisition.“Tilipalvelu Pirkko Kemppainen Oy has strong local knowledge of companies in the Northern Lapland region and special expertise in tourism and construction...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.